1.

Development of minimum standards of care for juvenile localized scleroderma.

Constantin T, Foeldvari I, Pain CE, Pálinkás A, Höger P, Moll M, Nemkova D, Weibel L, Laczkovszki M, Clements P, Torok KS.

Eur J Pediatr. 2018 Jul;177(7):961-977. doi: 10.1007/s00431-018-3144-8. Epub 2018 May 4. Review.

PMID:
29728839
2.

Chronic Recurrent Multifocal Osteomyelitis of the Mandible: A Diagnostic Challenge.

Camison L, Mai RS, Goldstein JA, Costello BJ, Torok KS, Losee JE.

Plast Reconstr Surg. 2018 Jul;142(1):186-192. doi: 10.1097/PRS.0000000000004494.

PMID:
29652766
3.

Detection of autoimmune antibodies in localized scleroderma by synthetic oligonucleotide antigens.

Samuelsen S, Jørgensen CD, Mellins ED, Torok KS, Astakhova K.

PLoS One. 2018 Apr 11;13(4):e0195381. doi: 10.1371/journal.pone.0195381. eCollection 2018.

4.

Clinical characteristics and factors associated with disability and impaired quality of life in children with juvenile systemic sclerosis.

Stevens BE, Torok KS, Li SC, Hershey N, Curran M, Higgins GC, Moore KF, Rabinovich CE, Dodson S, Stevens AM; CARRA Registry Investigators; Childhood Arthritis Rheumatology Research Alliance Stanford CA.

Arthritis Care Res (Hoboken). 2018 Feb 18. doi: 10.1002/acr.23547. [Epub ahead of print]

PMID:
29457372
5.

Brief Report: HLA-DRB1, DQA1, and DQB1 in Juvenile-Onset Systemic Sclerosis.

Stevens AM, Kanaan SB, Torok KS, Medsger TA, Mayes MD, Reveille JD, Klein-Gitelman M, Reed AM, Lee T, Li SC, Henstorf G, Luu C, Aydelotte T, Nelson JL.

Arthritis Rheumatol. 2016 Nov;68(11):2772-2777. doi: 10.1002/art.39765. Epub 2016 Oct 6.

6.

Predictors of Longitudinal Quality of Life in Juvenile Localized Scleroderma.

Ardalan K, Zigler CK, Torok KS.

Arthritis Care Res (Hoboken). 2017 Jul;69(7):1082-1087. doi: 10.1002/acr.23101. Epub 2017 Jun 7.

7.

Durometry as an outcome measure in juvenile localized scleroderma.

Poff S, Li SC, Kelsey CE, Foeldvari I, Torok KS.

Br J Dermatol. 2016 Jan;174(1):228-30. doi: 10.1111/bjd.14103. Epub 2015 Nov 18. No abstract available.

8.

Peripheral blood cytokine and chemokine profiles in juvenile localized scleroderma: T-helper cell-associated cytokine profiles.

Torok KS, Kurzinski K, Kelsey C, Yabes J, Magee K, Vallejo AN, Medsger T Jr, Feghali-Bostwick CA.

Semin Arthritis Rheum. 2015 Dec;45(3):284-93. doi: 10.1016/j.semarthrit.2015.06.006. Epub 2015 Jun 17.

9.

A Case Report of Successful Treatment of Recalcitrant Childhood Localized Scleroderma with Infliximab and Leflunomide.

Ferguson ID, Weiser P, Torok KS.

Open Rheumatol J. 2015 Jun 26;9:30-5. doi: 10.2174/18743129014090100030. eCollection 2015.

10.

Interferon-gamma inducible protein-10 as a potential biomarker in localized scleroderma.

Magee KE, Kelsey CE, Kurzinski KL, Ho J, Mlakar LR, Feghali-Bostwick CA, Torok KS.

Arthritis Res Ther. 2013;15(6):R188.

11.

Index of suspicion.

Lee B, Brown AG, Patel AM, Torok KS, Muhammad NA.

Pediatr Rev. 2013 Nov;34(11):531-6. doi: 10.1542/pir.34-11-531. No abstract available.

12.

The Localized Scleroderma Cutaneous Assessment Tool: responsiveness to change in a pediatric clinical population.

Kelsey CE, Torok KS.

J Am Acad Dermatol. 2013 Aug;69(2):214-20. doi: 10.1016/j.jaad.2013.02.007. Epub 2013 Apr 4.

13.

Coronary artery involvement in pediatric Takayasu's arteritis: Case report and literature review.

Mohan S, Poff S, Torok KS.

Pediatr Rheumatol Online J. 2013 Feb 12;11(1):4. doi: 10.1186/1546-0096-11-4.

14.

Pediatric scleroderma: systemic or localized forms.

Torok KS.

Pediatr Clin North Am. 2012 Apr;59(2):381-405. doi: 10.1016/j.pcl.2012.03.011. Epub 2012 Apr 6. Review.

15.

Development of consensus treatment plans for juvenile localized scleroderma: a roadmap toward comparative effectiveness studies in juvenile localized scleroderma.

Li SC, Torok KS, Pope E, Dedeoglu F, Hong S, Jacobe HT, Rabinovich CE, Laxer RM, Higgins GC, Ferguson PJ, Lasky A, Baszis K, Becker M, Campillo S, Cartwright V, Cidon M, Inman CJ, Jerath R, O'Neil KM, Vora S, Zeft A, Wallace CA, Ilowite NT, Fuhlbrigge RC; Childhood Arthritis and Rheumatology Research Alliance (CARRA) Localized Scleroderma Workgroup.

Arthritis Care Res (Hoboken). 2012 Aug;64(8):1175-85. doi: 10.1002/acr.21687.

16.

Methotrexate and corticosteroids in the treatment of localized scleroderma: a standardized prospective longitudinal single-center study.

Torok KS, Arkachaisri T.

J Rheumatol. 2012 Feb;39(2):286-94. doi: 10.3899/jrheum.110210. Epub 2012 Jan 15.

17.

Cytokine profiles in localized scleroderma and relationship to clinical features.

Kurzinski K, Torok KS.

Cytokine. 2011 Aug;55(2):157-64. doi: 10.1016/j.cyto.2011.04.001. Epub 2011 May 4. Review.

18.

Hypocomplementemia associated with macrophage activation syndrome in systemic juvenile idiopathic arthritis and adult onset still's disease: 3 cases.

Gorelik M, Torok KS, Kietz DA, Hirsch R.

J Rheumatol. 2011 Feb;38(2):396-7. doi: 10.3899/jrheum.100833. No abstract available.

19.

Improvement in medication education in a pediatric subspecialty practice.

Patel AM, Torok KS, Rosen P.

Pediatr Rheumatol Online J. 2010 Sep 15;8:25. doi: 10.1186/1546-0096-8-25.

20.

Reliability and validity of the delta finger-to-palm (FTP), a new measure of finger range of motion in systemic sclerosis.

Torok KS, Baker NA, Lucas M, Domsic RT, Boudreau R, Medsger TA Jr.

Clin Exp Rheumatol. 2010 Mar-Apr;28(2 Suppl 58):S28-36. Epub 2010 Jun 10.

21.

Autoimmune thyroiditis in antinuclear antibody positive children without rheumatologic disease.

Torok KS, Arkachaisri T.

Pediatr Rheumatol Online J. 2010 May 5;8:15. doi: 10.1186/1546-0096-8-15.

22.

Development and initial validation of the localized scleroderma skin damage index and physician global assessment of disease damage: a proof-of-concept study.

Arkachaisri T, Vilaiyuk S, Torok KS, Medsger TA Jr.

Rheumatology (Oxford). 2010 Feb;49(2):373-81. doi: 10.1093/rheumatology/kep361. Epub 2009 Dec 14.

23.

The localized scleroderma skin severity index and physician global assessment of disease activity: a work in progress toward development of localized scleroderma outcome measures.

Arkachaisri T, Vilaiyuk S, Li S, O'Neil KM, Pope E, Higgins GC, Punaro M, Rabinovich EC, Rosenkranz M, Kietz DA, Rosen P, Spalding SJ, Hennon TR, Torok KS, Cassidy E, Medsger TA Jr; Localized Scleroderma Clinical and Ultrasound Study Group.

J Rheumatol. 2009 Dec;36(12):2819-29. doi: 10.3899/jrheum.081284. Epub 2009 Oct 15.

24.

Index of suspicion.

Hall C, Friedland A, Sundar S, Torok KS, Bhende MS, Pecson G, Leedy C.

Pediatr Rev. 2008 Jan;29(1):25-30. doi: 10.1542/pir.29-1-25. No abstract available.

PMID:
18166618

Supplemental Content

Loading ...
Support Center